ATCC Receives Contract to Advance Industrial Biomanufacturing and Produce Synthetic Aviation Fuel Precursors
ATCC was granted a contract with Capra Biosciences to work on the DARPA Switch program to help identify novel metabolic feedstock utilization genes for use in new biomanufacturing technology.
ATCC Secures OASIS+ Multi-Agency Contract Vehicle from GSA
ATCC secures five-year, unrestricted OASIS+ multi-agency contract from GSA, expanding federal access to public health solutions.
ATCC Announces New Executive Leadership Appointments
ATCC promotes Rebecca Bradford to SVP and welcomes new executives Manoj Menon and Rupali Lach.
ATCC Appoints Dr. Ruth Cheng as New President and Chief Executive Officer
Ruth Cheng, appointed new president and CEO of ATCC, succeeds Raymond Cypess, who will remain on the Board of Directors as chairman.
ATCC Announces Award from NCI to Support Research and Vaccine Development for Cancer and HIV
NCI awarded ATCC a 5-year contract with a ceiling value of $4.06 million to provide lab services that support HIV and HTLV-1 research and vaccine development.
